Tuesday, June 9, 2009

BridgePoint Aims to Treat ChronicTotal Occlusions in Coronaries

Filed under: Cardiology , Radiology

BridgePoint Medical, out of Plymouth, MN, has developed innovative new catheters designed to cross chronic total coronary occlusions in native arteries, and reopen myocardial blood flow through vessels that everyone has given up on. Currently undergoing clinical trials, the CrossBoss™ CTO Catheter and the Stingray™ CTO Re-Entry System are yet to receive FDA approval.

More from BridgePoint about the devices:

Stingray:

The Stingray™ CTO Re-Entry System has two components: The Stingray™ CTO Orienting Balloon Catheter and The Stingray™ CTO Re-Entry Guidewire

Familiar coronary balloon catheter and guidewire designs are enhanced with custom features for CTO crossing without changing routine practice

Flat shape of the Stingray™ CTO Orienting Balloon Catheter is intended to orient one exit port automatically toward the vessel true lumen upon low pressure inflation (4atm)

The Stingray™ CTO Re-Entry Guidewire's distal probe is designed for exit port selection and re-entry into the vessel true lumen

CrossBoss™ CTO Catheter

Bi-directional rotation of the proximal torque device with the FAST SPIN Technique is designed to aid in advancement of the CrossBoss™ CTO Catheter

A 3.0F atraumatic rounded tip is designed for passage through the CTO

The device is intended to cross directly through the CTO or bypass the obstruction via a subintimal path

Device info page: Stingray™ CTO Re-Entry System

Video below the fold showing off the devices in greater detail:

READ MORE...

                (0)

Name:


Email Address
(will not be published):


URL:

Remember personal info?
(anonymous comments allowed)

Yes No

Comments:

Verification (needed to reduce spam):

Click the "Post" button only once!